Bank of New York Mellon’s Neuronetics STIM Stock Holding History
Bought
Maintained
Sold
Other funds holding STIM
CIAM
QC
DJYG
SOW
FCG
MMA
Bank of New York Mellon's STIM Position: Q2 2026 in Review
Bank of New York Mellon sold out of Neuronetics (STIM) in Q2 2026, closing a stake of 78,605 shares — an estimated $114K sold.
Bank of New York Mellon first reported a position in STIM in Q3 2018 and held it in 28 quarters. The position peaked at $1.72M in Q2 2021. 23 funds tracked by Wall St. Rank hold STIM as of Q2 2026.
- Bank of New York Mellon reported no remaining Neuronetics position as of Q2 2026 after selling out during the quarter.
- Bank of New York Mellon sold 78,605 Neuronetics shares in Q2 2026, an estimated $114K.
- Bank of New York Mellon first reported a position in Neuronetics in Q3 2018 and held it in 28 quarters.
- Bank of New York Mellon's Neuronetics position peaked at $1.72M in Q2 2021.
- 23 funds tracked by Wall St. Rank held Neuronetics as of Q2 2026.
Based on Bank of New York Mellon's 13F filing for Q2 2026, filed 6 Aug 2026.